triazolam has been researched along with Central Nervous System Disease in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 49-year-old woman treated with cimetidine 300 mg tid for more than 18 months for Zollinger-Ellison syndrome experienced lethargy, dizziness, ataxia, and auditory and visual hallucinations after receiving triazolam 0." | 3.67 | Central nervous system toxicity associated with concurrent use of triazolam and cimetidine. ( Britton, ML; Waller, ES, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Britton, ML | 1 |
| Waller, ES | 1 |
1 other study available for triazolam and Central Nervous System Disease
| Article | Year |
|---|---|
Central nervous system toxicity associated with concurrent use of triazolam and cimetidine.
Topics: Central Nervous System Diseases; Cimetidine; Drug Interactions; Female; Humans; Middle Aged; Triazol | 1985 |